Yasuhiko Hirabayashi
Overview
Explore the profile of Yasuhiko Hirabayashi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
324
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miyata M, Hirabayashi Y, Munakata Y, Urata Y, Saito K, Okuno H, et al.
Fukushima J Med Sci
. 2023 Mar;
69(1):11-20.
PMID: 36990790
Objectives: Methotrexate (MTX) is associated with extensive side effects, including myelosuppression, interstitial pneumonia, and infection. It is, therefore, critical to establish whether its administration is required after achieving remission with...
2.
Hirabayashi Y
Mod Rheumatol
. 2020 Dec;
31(5):966-971.
PMID: 33274666
Objectives: To assess whether tocilizumab (TCZ) can prevent bone destruction in patients with recent-onset rheumatoid arthritis (RA). Methods: DAS28-ESR and van der Heijde-modified Sharp score (mTSS) were evaluated in 50...
3.
Hirabayashi Y
Mod Rheumatol
. 2020 Apr;
31(1):70-79.
PMID: 32342712
Objectives: To assess the efficacy of tocilizumab (TCZ) in the treatment of persistent arthritis in patients with rheumatoid arthritis (RA). Methods: The response to TCZ was evaluated in 304 patients...
4.
Hirabayashi Y, Munakata Y, Miyata M, Urata Y, Saito K, Okuno H, et al.
Mod Rheumatol
. 2016 Mar;
26(6):828-835.
PMID: 26934116
Objective: To evaluate the clinical and structural efficacy of tocilizumab (TCZ) during its long-term administration in patients with rheumatoid arthritis (RA). Methods: In total, 693 patients with RA who started...
5.
Ogata A, Atsumi T, Fukuda T, Hirabayashi Y, Inaba M, Ishiguro N, et al.
Arthritis Care Res (Hoboken)
. 2015 Apr;
67(10):1354-62.
PMID: 25832859
Objective: To evaluate the efficacy and safety of switching from intravenous (IV) tocilizumab (TCZ) to subcutaneous (SC) TCZ monotherapy in rheumatoid arthritis patients. Methods: Patients who had completed 24 weeks...
6.
Watanabe R, Ishii T, Kobayashi H, Asahina I, Takemori H, Izumiyama T, et al.
Tohoku J Exp Med
. 2014 Jun;
233(2):129-33.
PMID: 24898712
Hepatitis B virus (HBV) reactivation has been increasingly recognized in patients receiving chemotherapy and immunosuppressive therapy; however, the prevalence of HBV infection and rate of HBV screening in patients with...
7.
Hirabayashi Y, Saito S, Takeshita M, Kodera T, Munakata Y, Ishii T, et al.
Mod Rheumatol
. 2014 Jan;
13(3):265-9.
PMID: 24387216
Abstract A 43-year-old woman with systemic lupus erythematosus (SLE) had an episode of mononeuritis multiplex prior to developing protein-losing gastroenteropathy. Four years later, she had another episode of mononeuritis multiplex,...
8.
Nishimoto N, Amano K, Hirabayashi Y, Horiuchi T, Ishii T, Iwahashi M, et al.
Mod Rheumatol
. 2013 Nov;
24(1):26-32.
PMID: 24261755
Objectives: To evaluate the safety and efficacy of retreatment with tocilizumab (TCZ) in patients who had participated in the DREAM study (Drug free remission/low disease activity after cessation of tocilizumab...
9.
Nishimoto N, Amano K, Hirabayashi Y, Horiuchi T, Ishii T, Iwahashi M, et al.
Mod Rheumatol
. 2013 Nov;
24(1):17-25.
PMID: 24261754
Objectives: To investigate the duration of remission and low disease activity (LDA) after cessation of tocilizumab (TCZ) treatment in rheumatoid arthritis patients who showed remission or LDA as assessed by...
10.
Watanabe R, Hirabayashi Y, Okuno H, Ishii T, Harigae H
Mod Rheumatol
. 2013 Nov;
24(6):1028-9.
PMID: 24251999
No abstract available.